Beate Suess
About Beate Suess
Beate Suess is a Regulatory Sciences Manager at Bristol-Myers Squibb in New York, with over 15 years of experience in regulatory affairs.
Company
Beate Suess is currently working at Bristol-Myers Squibb in New York, New York, United States. Bristol-Myers Squibb is a global biopharmaceutical company that develops and delivers innovative medicines. Beate has been part of this organization for over a decade, starting her role in February 2012.
Title
Beate Suess holds the position of Regulatory Sciences Manager. In this capacity, she is responsible for overseeing regulatory compliance, managing submissions, and ensuring that products meet all necessary regulatory standards.
Background in Regulatory Affairs
Beate Suess has extensive experience in regulatory affairs, having worked in this field for over 15 years. Prior to her current role, she worked as a Regulatory Affairs Manager at Cyathus Exquirere Pharmaforschungsgmbh from 2008 to 2012. This experience has given her a comprehensive understanding of regulatory processes and compliance standards.
Education and Expertise
Beate Suess studied at the University of Vienna, also known as Universität Wien. Her academic background has provided her with the foundational knowledge necessary for her roles in regulatory affairs and sciences. Her expertise is further reinforced by her extensive professional experience in this domain.
Research Associate at Vetmeduni Vienna
From 2004 to 2008, Beate Suess worked as a Research Associate at Vetmeduni Vienna. This position allowed her to engage in scientific research, which laid the groundwork for her future career in regulatory affairs. Working in Vienna, Austria, she gained valuable insights and experience that have contributed to her professional growth.
Career Transition to New York
Beate Suess relocated from Vienna, Austria, to New York, United States, for her role at Bristol-Myers Squibb. This transition marks a significant step in her career, allowing her to contribute her regulatory affairs expertise to a leading biopharmaceutical company in a global context.